Naila Rabbani

10.1k total citations · 1 hit paper
130 papers, 7.1k citations indexed

About

Naila Rabbani is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, Naila Rabbani has authored 130 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Clinical Biochemistry, 42 papers in Molecular Biology and 34 papers in Physiology. Recurrent topics in Naila Rabbani's work include Advanced Glycation End Products research (79 papers), Biochemical effects in animals (22 papers) and Genomics, phytochemicals, and oxidative stress (12 papers). Naila Rabbani is often cited by papers focused on Advanced Glycation End Products research (79 papers), Biochemical effects in animals (22 papers) and Genomics, phytochemicals, and oxidative stress (12 papers). Naila Rabbani collaborates with scholars based in United Kingdom, Qatar and Germany. Naila Rabbani's co-authors include Paul J. Thornalley, Mingzhan Xue, Roya Babaei‐Jadidi, Antonysunil Adaikalakoteswari, Attia Anwar, James R. Larkin, Martin O. Weickert, Amal Adnan Ashour, Usman Ahmed and Lisa Godfrey and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Naila Rabbani

128 papers receiving 7.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advanced glycation end products in the pathogenesis of chronic kidney disease

2018 287 citations Naila Rabbani, Paul J. Thornalley Kidney International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Naila Rabbani United Kingdom	50	3.8k	2.4k	1.8k	1.6k	869	130	7.1k
Takeshi Nishikawa Japan	35	2.0k 0.5×	3.0k 1.3×	1.7k 1.0×	2.1k 1.3×	473 0.5×	109	8.1k
Peter J. Oates United States	31	2.0k 0.5×	2.2k 0.9×	1.5k 0.8×	1.8k 1.1×	634 0.7×	53	6.6k
Michael Brownlee United States	35	4.3k 1.1×	4.4k 1.9×	3.3k 1.8×	3.2k 2.0×	861 1.0×	58	12.8k
Takanori Matsui Japan	54	4.3k 1.1×	2.3k 1.0×	3.7k 2.1×	1.1k 0.7×	833 1.0×	252	9.2k
Diane Edelstein United States	35	3.7k 1.0×	3.5k 1.5×	2.9k 1.6×	3.2k 2.0×	804 0.9×	47	11.1k
Karin Jandeleit‐Dahm Australia	57	2.2k 0.6×	3.7k 1.6×	2.4k 1.4×	1.8k 1.1×	538 0.6×	157	10.8k
Melinda T. Coughlan Australia	43	2.7k 0.7×	2.1k 0.9×	1.8k 1.0×	1.3k 0.8×	572 0.7×	97	6.7k
Reinhard Schinzel Germany	42	2.2k 0.6×	1.0k 0.4×	1.2k 0.7×	1.3k 0.8×	474 0.5×	101	4.8k
Weijing Cai United States	52	5.2k 1.4×	1.6k 0.7×	3.4k 1.9×	2.0k 1.2×	1.3k 1.5×	117	9.2k
Masayoshi Takeuchi Japan	62	7.3k 1.9×	2.8k 1.2×	5.0k 2.8×	1.8k 1.1×	1.8k 2.1×	256	12.4k

Countries citing papers authored by Naila Rabbani

Since Specialization

Citations

This map shows the geographic impact of Naila Rabbani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naila Rabbani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naila Rabbani more than expected).

Fields of papers citing papers by Naila Rabbani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naila Rabbani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naila Rabbani. The network helps show where Naila Rabbani may publish in the future.

Co-authorship network of co-authors of Naila Rabbani

This figure shows the co-authorship network connecting the top 25 collaborators of Naila Rabbani. A scholar is included among the top collaborators of Naila Rabbani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naila Rabbani. Naila Rabbani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xue, Mingzhan, et al.. (2024). Increased cellular protein modification by methylglyoxal activates endoplasmic reticulum-based sensors of the unfolded protein response. Redox Biology. 69. 103025–103025. 12 indexed citations

Nour‐Eldine, Wared, Kashif Rajpoot, Madeeha Kamal, et al.. (2023). Validation of plasma protein glycation and oxidation biomarkers for the diagnosis of autism. Molecular Psychiatry. 29(3). 653–659. 12 indexed citations

Masania, Jinit, Patrick Wijten, Susanne Keipert, et al.. (2022). Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle. Redox Biology. 59. 102574–102574. 5 indexed citations

Rabbani, Naila & Paul J. Thornalley. (2022). Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors. International Journal of Molecular Sciences. 23(5). 2453–2453. 26 indexed citations

Rabbani, Naila, Mingzhan Xue, & Paul J. Thornalley. (2022). Hexokinase-2-Linked Glycolytic Overload and Unscheduled Glycolysis—Driver of Insulin Resistance and Development of Vascular Complications of Diabetes. International Journal of Molecular Sciences. 23(4). 2165–2165. 34 indexed citations

Rabbani, Naila, Antonysunil Adaikalakoteswari, James R. Larkin, et al.. (2022). Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease. International Journal of Molecular Sciences. 24(1). 152–152. 16 indexed citations

Rabbani, Naila, Mingzhan Xue, & Paul J. Thornalley. (2021). Dicarbonyl stress, protein glycation and the unfolded protein response. Glycoconjugate Journal. 38(3). 331–340. 48 indexed citations

Ashour, Amal Adnan, et al.. (2020). Glycolytic overload-driven dysfunction of periodontal ligament fibroblasts in high glucose concentration, corrected by glyoxalase 1 inducer. BMJ Open Diabetes Research & Care. 8(2). e001458–e001458. 18 indexed citations

Rabbani, Naila, et al.. (2020). Vulnerabilities of the SARS-Cov-2 Virus to Proteotoxicity – Opportunity for Repurposed Chemotherapy of COVID-19 Infection. Qatar University QSpace (Qatar University). 314–314. 3 indexed citations

10.

Feskens, Edith J. M., Lorraine Brennan, Pierre Dussort, et al.. (2020). Potential Markers of Dietary Glycemic Exposures for Sustained Dietary Interventions in Populations without Diabetes. Advances in Nutrition. 11(5). 1221–1236. 9 indexed citations

11.

Masania, Jinit, Attia Anwar, Nasir Rajpoot, et al.. (2019). Urinary Metabolomic Markers of Protein Glycation, Oxidation, and Nitration in Early-Stage Decline in Metabolic, Vascular, and Renal Health. Oxidative Medicine and Cellular Longevity. 2019. 1–15. 19 indexed citations

12.

Xue, Mingzhan, et al.. (2019). Activation of the unfolded protein response in high glucose treated endothelial cells is mediated by methylglyoxal. Scientific Reports. 9(1). 7889–7889. 75 indexed citations

13.

Rabbani, Naila & Paul J. Thornalley. (2017). Glyoxalase 1 Modulation in Obesity and Diabetes. Antioxidants and Redox Signaling. 30(3). 354–374. 72 indexed citations

14.

Zhang, Fang, Jinit Masania, Attia Anwar, et al.. (2016). The uremic toxin oxythiamine causes functional thiamine deficiency in end-stage renal disease by inhibiting transketolase activity. Kidney International. 90(2). 396–403. 32 indexed citations

15.

Rabbani, Naila & Paul J. Thornalley. (2015). Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease. Biochemical and Biophysical Research Communications. 458(2). 221–226. 291 indexed citations

16.

Rabbani, Naila, et al.. (2015). Examination of methylglyoxal levels in an in vitro model of steatosis and serum from patients with non-alcoholic fatty liver disease. Proceedings of The Nutrition Society. 74(OCE1). 4 indexed citations

17.

Xue, Mingzhan, Hiroshi Momiji, Naila Rabbani, et al.. (2014). Frequency Modulated Translocational Oscillations of Nrf2 Mediate the Antioxidant Response Element Cytoprotective Transcriptional Response. Antioxidants and Redox Signaling. 23(7). 613–629. 72 indexed citations

18.

Rabbani, Naila & Paul J. Thornalley. (2011). Emerging role of thiamine therapy for prevention and treatment of early‐stage diabetic nephropathy. Diabetes Obesity and Metabolism. 13(7). 577–583. 60 indexed citations

19.

Thornalley, Paul J., Roya Babaei‐Jadidi, N. Karachalias, & Naila Rabbani. (2010). Prevention of decline in glycaemic control in streptozotocin-induced diabetic rats by thiamine but not by Benfotiamine. Diabetic Medicine. 2 indexed citations

20.

Rabbani, Naila & Paul J. Thornalley. (2008). The Dicarbonyl Proteome. Annals of the New York Academy of Sciences. 1126(1). 124–127. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact